Study Name: Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
10 locations found
- Beth Israel Deaconess Medical Center
Location: Boston, Massachusetts 02215
- Dartmouth-Hitchcock Medical Center
Location: Lebanon, New Hampshire 03756
- Memorial Sloan Kettering Cancer Center
Location: New York, New York 11065
- Fox Chase Cancer Center
Location: Rockledge, Pennsylvania 19111
- Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins
Location: Baltimore, Maryland 21231
- Levine Cancer Institute
Location: Charlotte, North Carolina 28204
- Tennessee Oncology, Pllc
Location: Nashville, Tennessee 37203
- Cleveland Clinic
Location: Cleveland, Ohio 44195
- The University of Texas MD Anderson Cancer Center
Location: Houston, Texas 77030
- City Of Hope
Location: Duarte, California 91010
|